The Heart Failure Policy Network


Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from Novartis Pharma. Additional support for The handbook launch in September 2018 has been provided by Bayer AG.  The content produced by the Network is not biased to any specific treatment or therapy, and is endorsed and owned by the Network’s members, who have full editorial control. All members provide their time for free.

20% of people are expected to live with heart failure at some point in life. This isn't a condition we can afford to ignore, that's why HFPN is fighting for better quality care.